About the Institute

The IQVIA Institute for Human Data Science contributes to the advancement of human health globally through timely research, insightful analysis and scientific expertise applied to granular non-identified patient-level data.

Fulfilling an essential need within healthcare, the Institute delivers objective, relevant insights and research that accelerate understanding and innovation critical to sound decision making and improved human outcomes. With access to IQVIA’s institutional knowledge, advanced analytics, technology and unparalleled data the Institute works in tandem with a broad set of healthcare stakeholders to drive a research agenda focused on Human Data Science, including government agencies, academic institutions, the life sciences industry and payers.

Featured Report

Medicine Use and Spending in the U.S.: A Review of 2018 and Outlook to 2023

This report provides objective measures of medicine use and its costs to the U.S. healthcare system and patients, employers, health plans, intermediaries and state and federal government agencies. The report specifically focuses on the volume of medicine use – with a special attention on opioids – drivers of change in the use of medicines, overall "net spending," out-of-pocket costs to patients, and an outlook through 2023 for the pharmaceuticals market. It additionally examines the key dynamics around new product launches, patent expiries and the introduction of generics and biosimilars.

Institute Leaders

Murray Aitken

Murray Aitken

Senior Vice President and
Executive Director

Michael Kleinrock

Michael Kleinrock

Director Research Development

Research Support

The IQVIA Institute leverages collaborative relationships in the public and private sectors to provide market clarity in advancing human science globally through fact based healthcare discussions.

LEARN MORE

EVENTS & WEBINARS
Find where Murray Aitken and Michael Kleinrock will be speaking next
MEDIA

See press releases and news coverage about the IQVIA Institute

Engage with Murray Aitken on Twitter